Intrinsiqs

Is Achieve Life Sciences, Inc. overvalued?

Achieve Life Sciences, Inc. (QUIT) — key valuation metrics and fundamentals.

No verdict
Price
$6.32
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$650.3M
Dividend yield
—
Return on equity
-225.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares QUIT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.